Division of Biotechnology Review and Research II Office of Biotechnology Products, Office of Pharmaceutical Quality Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Dr. Weiming Ouyang
Division of Biotechnology Review and Research II Office of Biotechnology Products, Office of Pharmaceutical Quality Center for Drug Evaluation and Research, U.S. Food and Drug Administration